IV 
118TH CONGRESS 
1ST SESSION 
H. RES. 700 
Expressing support for the designation of September 2023 as ‘‘National 
Prostate Cancer Awareness Month’’. 
IN THE HOUSE OF REPRESENTATIVES 
SEPTEMBER 19, 2023 
Mr. PAYNE (for himself, Mr. FITZPATRICK, Ms. ADAMS, Ms. CROCKETT, Mr. 
JACKSON of Illinois, Mr. MEEKS, Mr. CARTER of Louisiana, Mr. BACON, 
Mr. VEASEY, Mr. DAVIS of North Carolina, Ms. CLARKE of New York, 
Mr. CARSON, Ms. WILLIAMS of Georgia, Mr. GRIJALVA, Mr. HUNT, Mr. 
JOHNSON of Georgia, Mr. DUNN of Florida, Mr. LIEU, Mr. GROTHMAN, 
Mr. MENENDEZ, Mr. VALADAO, Mr. WESTERMAN, Ms. CARAVEO, and 
Mr. BISHOP of Georgia) submitted the following resolution; which was re-
ferred to the Committee on Energy and Commerce 
RESOLUTION 
Expressing support for the designation of September 2023 
as ‘‘National Prostate Cancer Awareness Month’’. 
Whereas more than 3,100,000 men have at some point been 
diagnosed with prostate cancer and are still alive in the 
United States; 
Whereas 1 in 8 men in the United States will be diagnosed 
with prostate cancer in their lifetimes and 1 in 41 men 
in the United States will die from prostate cancer; 
Whereas prostate cancer is the most commonly diagnosed 
nonskin cancer and the second-leading cause of cancer- 
related deaths among men in the United States; 
VerDate Sep 11 2014 
22:43 Sep 19, 2023
Jkt 039200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6300
E:\BILLS\HR700.IH
HR700
kjohnson on DSK7ZCZBW3PROD with $$_JOB
•HRES 700 IH 
Whereas the American Cancer Society estimates that, in 
2023, 288,300 men will be diagnosed with, and more 
than 34,700 men will die of, prostate cancer; 
Whereas 40 percent of newly diagnosed prostate cancer cases 
occur in men under the age of 65; 
Whereas the odds of developing prostate cancer rise rapidly 
after age 50; 
Whereas African-American men suffer from a prostate cancer 
incidence rate that is significantly higher than that of 
White men and have more than double the prostate can-
cer mortality rate than that of White men; 
Whereas having a father or brother with prostate cancer 
more than doubles the risk of a man developing prostate 
cancer, with a higher risk for men who have a brother 
with the disease and the highest risk for men with several 
affected relatives; 
Whereas screening by a digital rectal examination and a pros-
tate-specific antigen blood test can detect the disease at 
the earlier, more treatable stages, which could increase 
the chances of survival for more than 5 years to nearly 
100 percent; 
Whereas only 32 percent of men survive more than 5 years 
if diagnosed with prostate cancer after the cancer has 
metastasized; 
Whereas there are typically no noticeable symptoms of pros-
tate cancer in the early stages, making appropriate 
screening critical; 
Whereas, in fiscal year 2023, Congress appropriated 
$47,500,000,000 to the National Institutes of Health, in-
cluding $7,104,159,000 for the National Cancer Insti-
tute; 
VerDate Sep 11 2014 
22:43 Sep 19, 2023
Jkt 039200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6300
E:\BILLS\HR700.IH
HR700
kjohnson on DSK7ZCZBW3PROD with $$_JOB
•HRES 700 IH 
Whereas, in fiscal year 2023, Congress appropriated 
$110,000,000 for the peer-reviewed Prostate Cancer Re-
search Program of the Department of Defense; 
Whereas the Department of Veterans Affairs has established 
21 Precision Oncology Centers of Excellence in order to 
deliver precision oncology services to veterans suffering 
from prostate cancer; 
Whereas ongoing research promises further improvements in 
prostate cancer prevention, early detection, and treat-
ment; and 
Whereas educating people in the United States, including 
health care providers, about prostate cancer and early de-
tection strategies is crucial to saving the lives of men and 
preserving and protecting families: Now, therefore, be it 
Resolved, That the House of Representatives— 
(1) expresses support for the designation of 
‘‘National Prostate Cancer Awareness Month’’; 
(2) declares that steps should be taken— 
(A) to raise awareness about the impor-
tance of screening methods for, and treatment 
of, prostate cancer; 
(B) to encourage research— 
(i) to improve screening and treat-
ment for prostate cancer; 
(ii) to discover the causes of prostate 
cancer; and 
(iii) to develop a cure for prostate 
cancer; and 
VerDate Sep 11 2014 
22:43 Sep 19, 2023
Jkt 039200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\HR700.IH
HR700
kjohnson on DSK7ZCZBW3PROD with $$_JOB
•HRES 700 IH 
(C) to continue to consider ways to im-
prove access to, and the quality of, health care 
services for detecting and treating prostate can-
cer; and 
(3) calls on the people of the United States, in-
terest groups, and affected persons— 
(A) to promote awareness of prostate can-
cer; 
(B) to take an active role in the fight to 
end the devastating effects of prostate cancer 
on individuals, families, and the economy; and 
(C) to observe National Prostate Cancer 
Awareness Month with appropriate ceremonies 
and activities. 
Æ 
VerDate Sep 11 2014 
22:43 Sep 19, 2023
Jkt 039200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6301
E:\BILLS\HR700.IH
HR700
kjohnson on DSK7ZCZBW3PROD with $$_JOB